Gottlieb: FDA Will Increase Inspections of Stem Cell Facilities

Drug Industry Daily
A A
The FDA will step up enforcement efforts against stem cell clinics in the coming months, Commissioner Scott Gottlieb told participants at the FDLI Enforcement, Litigation and Compliance Conference in Washington, D.C., on Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily